Related Experiment Video
Updated: Dec 13, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Optimizing an ultrasound contrast agent's stability using in vitro attenuation measurements
Jean-Michel Correas1, Erol Kurtisovski, S Lori Bridal
1Laboratoire d'Imagerie Paramétrique, University of Paris, France. jean-michel.correas@nck.ap-hop-paris.fr
Ultrasound contrast agent (USCA) microbubble stability decreases over time after reconstitution, especially at lower concentrations. Optimizing Levovist use involves adhering to recommended reconstitution times and concentrations for improved persistence.
Area of Science:
- Medical Imaging
- Ultrasound Technology
- Contrast Agents
Background:
- Ultrasound contrast agents (USCAs) enhance diagnostic imaging.
- Levovist, a galactose-based USCA, is widely used.
- Understanding microbubble dynamics is crucial for optimizing clinical application.
Purpose of the Study:
- To assess changes in microbubble populations of Levovist.
- To optimize clinical use of this ultrasound contrast agent.
- To evaluate microbubble behavior using attenuation measurements.
Main Methods:
- In vitro characterization of Levovist microbubbles.
- Attenuation measurements were employed.
- Varied parameters included dose, concentration, and time since reconstitution.
Main Results:
- A linear relationship was observed between attenuation and USCA amount two minutes post-reconstitution.
- Microbubble stability significantly decreased with increased time since reconstitution.
- Lower concentrations showed a more pronounced reduction in stability.
Conclusions:
- Levovist persistence and contrast enhancement are influenced by reconstitution time and concentration.
- Recommended minimum reconstitution time and maximum concentration improve USCA performance.
- Clinical application of Levovist can be optimized through controlled preparation.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
In Vitro Drug Dissolution: Compendial Testing Models II
In Vitro Drug Dissolution: Compendial Testing Models I
Drug Product Stability
In Vitro Drug Dissolution: Alternative Methods
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

